Clinical Nuclear Medicine · 2009 · 119 citations · 16 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyBrain ImagingBrain TumorsNeuro-oncologic ImagingNeuro-oncology ImagingPositron Emission TomographyTumor Imaging18F-fluorodeoxyglucose Imaging18F-fluorodeoxyglucose Positron Emission TomographyFluorine-18 Fluorodeoxyglucose Positron Emission TomographyLow-grade Glioma RecurrenceMetabolic Brain ImagingMetabolic ImagingMetabolic Tumor ImagingPet Tracers
INTRODUCTION: We undertook this prospective study to compare amino acid metabolism, glucose metabolism, and proliferation in primary and recurrent low grade gliomas using positron emission tomography (PET)/computed tomography with F-18 FDOPA, F-18 FDG, and F-18 FLT. METHODS: Fifteen patients with newly diagnosed or previously treated low grade gliomas (WHO grade I or II) were subjected to F-18-FDOPA, F-18 FDG, and F-18 FLT PET/computed tomography studies on consecutive days. This included 2 patients in remission as control subjects. Uptake of all the 3 tracers were analyzed visually and quantified using standardized uptake values and tumor to normal (T/N) ratios. The accuracy of all the 3 PET tracers in the detection of newly diagnosed and recurrent low grade gliomas was compared. RESULTS: F-18 FDOPA was positive in all cases of primary and recurrent low grade gliomas and negative in the patients in remission. Tumor was visualized on F-18 FDG in 7 of 13 cases, F-18-FLT was positive in 4 of 13 cases. Average tumor standardized uptake values max for F-18 FDOPA (5.75 +/- 4.9) and F-18 FLT (1.8 +/- 0.91) was lower than that of F-18 FDG (8.5 +/- 4.4). T/N ratios for F-18-FDOPA (2.3 +/- 0.51) and F-18 FLT (1.8 +/- 0.91) were higher than F-18 FDG (1.03 +/- 0.64) providing good image contrast for tumor detection in positive cases. CONCLUSION: F-18 FDOPA scan is superior to both F-18 FLT and F-18 FDG for visualization of primary and recurrent low grade gliomas. F-18-FLT should not be considered for evaluation of recurrent low grade gliomas.
16
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Anthony F. Shields, John R. Grierson, Bernhard M. Dohmen et al. · Nature Medicine · 1998 · 1.2K citations
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
PL Jager, Willem Vaalburg, Jan Pruim et al. · PubMed · 2001 · 556 citations
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Wei Chen, Timothy F. Cloughesy, Nirav Kamdar et al. · PubMed · 2005 · 440 citations
Medicine, Nuclear Medicine, Oncology +17
Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
Janet S. Rasey, John R. Grierson, Linda Wiens et al. · PubMed · 2002 · 407 citations